FDA Approves Zanidatamab Regimens for HER2-Positive GEA
"FDA Approves Zanidatamab-Based Regimens for First-Line HER2-Positive Gastroesophageal Adenocarcinoma" Read the full news breakdown: 247qualitymeds.com/blog/fda-app... What does the FDA approval of zanidatamab (Ziihera) mean for HER2-positive GEA? Read about its mechanism and key trial results.